Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00769769 · ClinicalTrials.gov registry record · Phase 3

Comparing Delivery Methods of Cognitive Behavioral Therapy for Depressed African-American Dementia Caregivers

A Phase 3 study of Depression, sponsored by Robert L. Glueckauf.

Completed
Registry status
Phase 3
Development phase
106
Enrollment target
1
Study location

NCT00769769: Completed Phase 3 study of Depression, sponsored by Robert L. Glueckauf.

NCT00769769 is a Phase 3 study of Depression that has completed, run by Robert L. Glueckauf. The registered enrollment target is 106 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00769769, a Phase 3 study of Depression, has completed, sponsored by Robert L. Glueckauf.

COMPLETED
Registry status
Phase 3
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

This study will compare the effectiveness of face-to-face cognitive behavioral therapy versus telephone-based cognitive behavioral therapy for treating African Americans who care for family members with dementia.

Conditions Studied

Interventions

  • BEHAVIORAL Psychotherapy

Study Locations (1)

Florida

  • Florida State University College of Medicine - Tallahassee

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2008-10
Est. Completion 2012-02
Phase Phase 3
Robert L. Glueckauf

1 total trials

What the finished NCT00769769 record still lists

NCT00769769 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Psychotherapy is the first listed.

NCT00769769 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT00769769 about?

NCT00769769 is a clinical study titled "Comparing Delivery Methods of Cognitive Behavioral Therapy for Depressed African-American Dementia Caregivers". This study will compare the effectiveness of face-to-face cognitive behavioral therapy versus telephone-based cognitive behavioral therapy for treating African Americans who care for family members with dementia.

What is the current status of trial NCT00769769?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 106 participants. The study started on 2008-10. Estimated completion is 2012-02.

What conditions does trial NCT00769769 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00769769?

The interventions under investigation include: Psychotherapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00769769?

This trial is sponsored by Robert L. Glueckauf, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00769769 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00769769's enrollment target sits among peer trials

106 317th of 679 higher than 361 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00769769, the US trial registry maintained by the National Library of Medicine. NCT00769769 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.